Health Care & Life Sciences » Pharmaceuticals | MaYinglong Pharmaceutical Group Co. Ltd.

MaYinglong Pharmaceutical Group Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
853
783
929
980
1,400
1,472
Total Accounts Receivable
493
576
543
547
435
526
Inventories
184
236
215
212
200
229
Other Current Assets
39
34
49
46
57
39
Total Current Assets
1,570
1,629
1,736
1,786
2,091
2,267
Net Property, Plant & Equipment
274
308
407
387
345
324
Total Investments and Advances
87
128
143
195
191
207
Intangible Assets
40
47
50
54
52
52
Other Assets
45
62
59
63
61
47
Total Assets
2,027
2,186
2,410
2,497
2,754
2,927
ST Debt & Current Portion LT Debt
75
144
172
119
22
Accounts Payable
153
121
134
112
73
Income Tax Payable
45
40
25
18
22
Other Current Liabilities
184
171
174
166
248
Total Current Liabilities
457
476
506
415
365
Long-Term Debt
-
-
-
5
90
Deferred Taxes
11
12
14
11
6
Other Liabilities
-
-
-
38
-
Total Liabilities
457
476
506
459
463
Common Equity (Total)
1,426
1,570
1,784
1,940
2,192
Total Shareholders' Equity
1,426
1,570
1,784
1,940
2,192
Total Equity
1,566
1,699
1,887
2,017
2,271
Liabilities & Shareholders' Equity
2,027
2,186
2,410
2,497
2,754
Accumulated Minority Interest
140
128
102
77
79
Non-Equity Reserves
4
11
17
21
20

About MaYinglong Pharmaceutical Group Co.

View Profile
Address
No. 100 Zhoujiawan
Wuhan Hubei 430064
China
Employees -
Website -
Updated 07/08/2019
Mayinglong Pharmaceutical Group Co., Ltd. engages in the manufacture of pharmaceutical products. It involves in the following business activities through its subsidiaries: operation of anorectal hospitals and clinics; and retail and wholesale of medicines. Its products include hemorrhoids cream, treatment for skin disease, and cough suppressants.